Le Lézard
Classified in: Health
Subject: SVY

Global protein assays market is expected to grow with a CAGR of 10.6% over the forecast period from 2019-2025


NEW YORK, April 23, 2019 /PRNewswire/ -- The report on the global protein assays market provides qualitative and quantitative analysis for the period from 2017 to 2025.



Read the full report: https://www.reportlinker.com/p05765595/?utm_source=PRN



The report predicts the global protein assays market to grow with a CAGR of 10.6% over the forecast period from 2019-2025. The study on protein assays market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on protein assays market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global protein assays market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global protein assays market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings
1) Drivers
? An increasing number of patient chronic diseases such as neurological or cardiovascular diseases.
? The rapid increase in healthcare and the pharmaceutical industry.
2) Restraints
? Strict government regulation for drugs.
3) Opportunities
? Increasing demand for point of care.

Research Methodology

A) Primary Research
Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include
1. Key Opinion Leaders associated with Infinium Global Research
2. Internal and External subject matter experts
3. Professionals and participants from the industry

Our primary research respondents typically include
1. Executives working with leading companies in the market under review
2. Product/brand/marketing managers
3. CXO level executives
4. Regional/zonal/ country managers
5. Vice President level executives.

B) Secondary Research
Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources.

The secondary sources of the data typically include
1. Company reports and publications
2. Government/institutional publications
3. Trade and associations journals
4. Databases such as WTO, OECD, World Bank, and among others.
5. Websites and publications by research agencies

Segment Covered
The global protein assays market is segmented on the basis of product, type, application, and end-user.

The Global Protein Assays Market by Product
? Kits
? Reagents
? Instruments & Accessories

The Global Protein Assays Market by Type
? Copper-ion-based Assays
? Dye-binding Assays
? Test Strip-based Assays

The Global Protein Assays Market by Application
? Disease Diagnosis
? Drug Discovery & Development
? Others

The Global Protein Assays Market by End-User
? Hospitals
? Pharmaceutical and Biotechnology Companies
? Academic Research Institutes
? Clinical Laboratories
? Others

Company Profiles
? Thermo Fisher Scientific Inc.
? PerkinElmer Inc.
? Abcam PLC.
? GE Healthcare
? Bio-Rad Laboratories, Inc.
? Novus Biologicals, LLC
? Geno Technology, Inc.
? Merck KGaA
? BioVision Inc.
? Lonza Group

What does this report deliver?
1. Comprehensive analysis of the global as well as regional markets of the protein assays market.
2. Complete coverage of all the segments in the protein assays market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global protein assays market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Read the full report: https://www.reportlinker.com/p05765595/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: